id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0152-0007,FDA,FDA-2011-E-0152,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T18:17:27Z,,0,0,090000648119c9b4
FDA-2011-E-0152-0006,FDA,FDA-2011-E-0152,Determination of Regulatory Review Periods for Patent Extension: LATUDA,Notice,General Notice,2012-04-06T04:00:00Z,2012,4,2012-04-06T04:00:00Z,2012-05-06T03:59:59Z,2012-04-06T13:20:23Z,2012-08354,0,0,0900006480feaa50
FDA-2011-E-0152-0005,FDA,FDA-2011-E-0152,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-04-03T04:00:00Z,2012,4,2012-04-03T04:00:00Z,,2012-04-03T19:23:34Z,,0,0,0900006480fe7bb7